Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Journal Article (Clinical Trial;Journal Article)
Full Text
Duke Authors
Cited Authors
- Gockerman, JP; Silberman, H; Bartolucci, AA
Published Date
- July 1, 1987
Published In
Volume / Issue
- 71 / 7-8
Start / End Page
- 773 - 774
PubMed ID
- 3300970
International Standard Serial Number (ISSN)
- 0361-5960
Language
- eng
Conference Location
- United States